# Boston Scientific Corporation (BSX) — Q3-2022 Earnings Results

**Report date:** 2022-10-26 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BSX/earnings/Q3-2022

## Post-Earnings Brief

### Headline

Boston Scientific Misses on EPS, Stock Up 1.19%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.43 | N/A | -2.93% |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management acknowledged the current market conditions while emphasizing their commitment to innovation. They remain focused on long-term strategies despite short-term challenges.

**Key quotes:**

> Management highlighted ongoing challenges in the market but expressed confidence in long-term growth.

> They noted that innovation remains a key focus area for the company.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Boston Scientific's earnings report shows a slight miss on EPS, which may raise concerns among some investors. However, the stock reacted positively, increasing by 1.19%, likely due to management's focus on innovation and long-term growth strategies. The lack of guidance may leave some investors cautious, but the overall tone from management was optimistic.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BSX/earnings/Q3-2022_